Stopped Manufacturing, Supply Of Covishield Vaccine Since December 2021: SII

Mumbai: Serum Institute of India (SII), which produced AstraZeneca’s Covid vaccine under the brand name Covishield, on May 8 said it has stopped the manufacturing and supply of additional doses of the vaccine since December 2021.

Following the withdrawal of the Covid vaccine by AstraZeneca, SII said it acknowledges and fully understands the ongoing concerns around UK pharma major’s vaccine.

An SII spokesperson said it is committed to transparency and safety and had taken all the required steps to disclose the rare side effects of the vaccine.

On May 7, it was reported that the UK firm has announced that it will withdraw its Covid vaccine globally, citing an abundance of newer vaccine options available.

Additionally, AstraZeneca plans to revoke marketing authorisations for its vaccine, Vaxzevria, within Europe due to reduced demand and discontinuation of production and supply.

“As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company said.

The UK drugmaker had recently admitted in a court that the vaccine can cause a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).

The admission comes amid legal proceedings prompted by claims of serious health complications, including death, attributed to the vaccine. Lawyers representing numerous claimants argue that some cases could result in compensation payouts totaling up to 20 million pounds.

Related Posts

  • Pharma
  • May 25, 2024
  • 63 views
NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of asthma inhaler drug combination formoteral 6 mcg and budesonide 400 mcg dry power inhaler (DPI) under…

  • Pharma
  • May 25, 2024
  • 71 views
Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Jaipur: To provide quality education in pharmacy institutes, the central government has prepared to end the duplicate system. Strict action will be taken against fake students and teachers in newly opened…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

A Doctor diagnoses Mood of Voters in Delhi

A Doctor diagnoses Mood of Voters in Delhi

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research